At the news
? NEUTRALIMPACT 2/10 144 filed Nov 9, 2026 at 16:07 ET
Christoph Brackmann, an officer of NovoCure, filed a Form 144 notice of intent to sell 7,343 shares of common stock, with an approximate market value of $94,446 based on a filing date price. The sale represents a small fraction of the company's $1.6B market cap and is a routine insider disposition.
- Reporting owner: Christoph Brackmann, an officer of NovoCure Ltd
- Securities to be sold: 7,343 shares of common stock
- Approximate value of shares: $94,445.67
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access